fluoxetine has been researched along with phosphotyrosine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Falcon, R; González, I; Jorquera, F; Monari, M; Orrego, F; Sandoval, M; Sandoval, S; Vargas, F; Wyneken, U | 1 |
1 other study(ies) available for fluoxetine and phosphotyrosine
Article | Year |
---|---|
Clinically relevant doses of fluoxetine and reboxetine induce changes in the TrkB content of central excitatory synapses.
Topics: Animals; Antidepressive Agents; Blotting, Western; Brain; Brain-Derived Neurotrophic Factor; Dose-Response Relationship, Drug; Fluoxetine; Glutamic Acid; Immunoprecipitation; Male; Morpholines; Phosphotyrosine; rab5 GTP-Binding Proteins; Rats; Rats, Sprague-Dawley; Reboxetine; Receptor, trkB; Subcellular Fractions; Synapses; Time Factors | 2006 |